학술논문

Phase I/II Report from a Multicenter Trial of Perifosine (KRX-0401) + Bortezomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma Previously Treated with Bortezomib.
Document Type
Abstract
Source
In Blood 16 November 2007 110(11):1170-1170
Subject
Language
ISSN
0006-4971